Literature DB >> 8024006

Hypertrophic growth of cultured neonatal rat heart cells mediated by type 1 angiotensin II receptor.

S Miyata1, T Haneda.   

Abstract

Primary cultures of neonatal cardiac myocytes were used to determine the identity of second messengers that are involved in angiotensin II (ANG II) receptor-mediated effects on cardiac hypertrophy and the type of ANG II receptor that is involved in ANG II-induced cell growth. Treatment of myocytes with ANG II significantly increased the protein-to-DNA and the RNA-to-DNA ratios. ANG II accelerated rates of protein synthesis by 24.9%. Intracellular free calcium was transiently increased after ANG II exposure. The activity of protein kinase C in particulate fractions was transiently increased after exposure to ANG II but returned to control level. The activity of protein kinase C in the cytosol was significantly decreased at all times after exposure to ANG II. After ANG II treatment, the content of c-Fos mRNA was increased. The stimulatory effects of ANG II on these parameters were inhibited by the type 1 angiotensin II receptor (AT1) antagonist, losartan. These studies demonstrate that ANG II-induced hypertrophic growth is, at least in part, mediated through AT1 receptors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8024006     DOI: 10.1152/ajpheart.1994.266.6.H2443

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  13 in total

1.  Angiotensin II stimulates hyperplasia but not hypertrophy in immature ovine cardiomyocytes.

Authors:  N C Sundgren; G D Giraud; P J S Stork; J G Maylie; K L Thornburg
Journal:  J Physiol       Date:  2003-03-07       Impact factor: 5.182

Review 2.  The renin-angiotensin system and the heart: beyond 2000.

Authors:  T Morgan; H R Brunner
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

Review 3.  Is there an internal cardiac renin-angiotensin system?

Authors:  A H Danser; M A Schalekamp
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

4.  Early expression of all the components of the renin-angiotensin-system in human development.

Authors:  S Schütz; J M Le Moullec; P Corvol; J M Gasc
Journal:  Am J Pathol       Date:  1996-12       Impact factor: 4.307

Review 5.  Neurohormonal connections with mitochondria in cardiomyopathy and other diseases.

Authors:  Gerald W Dorn
Journal:  Am J Physiol Cell Physiol       Date:  2022-06-27       Impact factor: 5.282

6.  Oxidative stress-mediated effects of angiotensin II in the cardiovascular system.

Authors:  Hairuo Wen; Judith K Gwathmey; Lai-Hua Xie
Journal:  World J Hypertens       Date:  2012-08-23

7.  Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death.

Authors:  Hong D Xiao; Sebastien Fuchs; Duncan J Campbell; William Lewis; Samuel C Dudley; Vijaykumar S Kasi; Brian D Hoit; George Keshelava; Hui Zhao; Mario R Capecchi; Kenneth E Bernstein
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

8.  Ca2+ oscillation frequency decoding in cardiac cell hypertrophy: role of calcineurin/NFAT as Ca2+ signal integrators.

Authors:  Matilde Colella; Francesca Grisan; Valerie Robert; Jay D Turner; Andrew P Thomas; Tullio Pozzan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

9.  Inhibition of angiotensin II Gq signaling augments beta-adrenergic receptor mediated effects in a renal artery stenosis model of high blood pressure.

Authors:  David M Harris; Xiongwen Chen; Stéphanie Pesant; Heather I Cohn; Scott M MacDonnell; Matthieu Boucher; Leif E Vinge; Philip Raake; Susan R Moraca; Dongjun Li; Patrick Most; Steven R Houser; Walter J Koch; Andrea D Eckhart
Journal:  J Mol Cell Cardiol       Date:  2008-09-30       Impact factor: 5.000

10.  Thrombospondins in the heart: potential functions in cardiac remodeling.

Authors:  Mark W M Schellings; Geert C van Almen; E Helene Sage; Stephane Heymans
Journal:  J Cell Commun Signal       Date:  2009-10-02       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.